Physician profile
Erika Blanton
NPI 1174579296
$420.83
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2023: $19.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $67.56 | 2019 | |
| Amag Pharmaceuticals, INC. | $62.63 | 2019 | |
| Abbvie INC. | $61.94 | 2019 | |
| Coopersurgical, INC. | $45.38 | 2019 | |
| Therapeuticsmd, INC. | $42.80 | 2019 | |
| Duchesnay USA Incorporated | $42.25 | 2019 | |
| Pfizer INC. | $26.44 | 2019 | |
| Vertical Pharmaceuticals, LLC | $23.93 | 2019 | |
| Hologic Sales and Service, LLC | $19.67 | 2023 | Thinprep 2000 Processor, Aptima |
| Merck Sharp & Dohme LLC | $16.99 | 2019 | |
| Lupin INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Blanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.